Remdesivir
Generic name: Remdesivir
Brand names: Veklury
Drug class:
Purine nucleosides
Usage of Remdesivir
Remdesivir is used to treat adults and children at least 28 days and older who weigh at least 7 pounds (3 kilograms) with positive results for COVID-19 who are:
Remdesivir may also be used for purposes not listed in this medication guide.
Remdesivir side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during or after the injection. Tell your caregiver right away if you have:
Common side effects of remdesivir may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Remdesivir
You should not be treated with remdesivir if you are allergic to it.
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or plan to become pregnant, or if you are breastfeeding.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of remdesivir on the baby.
Relate drugs
- Acyclovir
- Acyclovir (Buccal mucosa)
- Acyclovir (Oral, Intravenous)
- Acyclovir injection
- Cytovene
- Cytovene IV
- Brincidofovir
- Cidofovir
- Famciclovir
- Famvir
- Ganciclovir (Oral, Intravenous)
- Ganciclovir injection
- Moderiba
- Remdesivir
- Sitavig
- Tembexa
- Valacyclovir
- Valcyte
- Valganciclovir
- Valtrex
- Veklury
- Vistide
- Zovirax
- Zovirax (Acyclovir Oral, Intravenous)
How to use Remdesivir
Usual Adult Dose for COVID-19:
Loading dose (Day 1): 200 mg IV as a single doseMaintenance dose (from Day 2): 100 mg IV once a dayDuration of Therapy:-Hospitalized patients requiring invasive mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO): 10 days total-Hospitalized patients not requiring invasive mechanical ventilation and/or ECMO: 5 days; may extend up to 5 additional days (for a total of up to 10 days) if no clinical improvement shown-Nonhospitalized patients: 3 days totalUse: For the treatment of coronavirus disease 2019 (COVID-19) in patients who are:-Hospitalized, or-Not hospitalized, have mild to moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death
Usual Pediatric Dose for COVID-19:
28 Days of Age and Older:Weight 3 to less than 40 kg:-Loading dose (Day 1): 5 mg/kg IV as a single dose-Maintenance dose (from Day 2): 2.5 mg/kg IV once a dayWeight at least 40 kg:-Loading dose (Day 1): 200 mg IV as a single dose-Maintenance dose (from Day 2): 100 mg IV once a dayDuration of Therapy:-Hospitalized patients requiring invasive mechanical ventilation and/or ECMO: 10 days total-Hospitalized patients not requiring invasive mechanical ventilation and/or ECMO: 5 days; may extend up to 5 additional days (for a total of up to 10 days) if no clinical improvement shown-Nonhospitalized patients: 3 days totalComments:-The lyophilized powder formulation is the only approved dosage form for pediatric patients weighing 3 to less than 40 kg.Use: For the treatment of COVID-19 in patients who are:-Hospitalized, or-Not hospitalized, have mild to moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death
Warnings
Remdesivir is for use only in people with COVID-19. You must remain under the care of a doctor while receiving remdesivir.
What other drugs will affect Remdesivir
Tell your doctor if you also take chloroquine or hydroxychloroquine. Either of these other medicines could make remdesivir less effective.
Other drugs may affect remdesivir, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions